Erika J. Lampert

1.1k total citations
27 papers, 778 citations indexed

About

Erika J. Lampert is a scholar working on Reproductive Medicine, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Erika J. Lampert has authored 27 papers receiving a total of 778 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Reproductive Medicine, 9 papers in Pathology and Forensic Medicine and 8 papers in Oncology. Recurrent topics in Erika J. Lampert's work include Ovarian cancer diagnosis and treatment (11 papers), Multiple Sclerosis Research Studies (6 papers) and PARP inhibition in cancer therapy (6 papers). Erika J. Lampert is often cited by papers focused on Ovarian cancer diagnosis and treatment (11 papers), Multiple Sclerosis Research Studies (6 papers) and PARP inhibition in cancer therapy (6 papers). Erika J. Lampert collaborates with scholars based in United States, Spain and Canada. Erika J. Lampert's co-authors include Tzu‐Ting Huang, Jungmin Lee, Magí Andorrà, Albert Saiz, Elena H. Martínez‐Lapiscina, Sara Llufriú, Pablo Villoslada, Jayakumar R. Nair, Ashley Cimino‐Mathews and Adam DePriest and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Erika J. Lampert

24 papers receiving 772 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erika J. Lampert United States 15 229 224 165 145 109 27 778
Quancai Cui China 20 281 1.2× 411 1.8× 157 1.0× 76 0.5× 158 1.4× 61 1.0k
Blanca Cantos Spain 15 401 1.8× 460 2.1× 202 1.2× 130 0.9× 187 1.7× 49 961
Anna F. Lee Canada 16 279 1.2× 433 1.9× 384 2.3× 134 0.9× 96 0.9× 44 1.1k
Edwin Alvarez United States 12 290 1.3× 202 0.9× 109 0.7× 61 0.4× 74 0.7× 31 734
Chiara Della Pepa Italy 15 250 1.1× 199 0.9× 174 1.1× 70 0.5× 158 1.4× 22 640
Meng Huang China 15 183 0.8× 200 0.9× 112 0.7× 44 0.3× 180 1.7× 49 640
Hong-Jun Song China 20 231 1.0× 209 0.9× 233 1.4× 51 0.4× 160 1.5× 57 1.1k
Matthew Vaughan United Kingdom 9 161 0.7× 187 0.8× 186 1.1× 36 0.2× 92 0.8× 17 554
G Wolf Austria 19 287 1.3× 383 1.7× 111 0.7× 211 1.5× 249 2.3× 50 1.2k
Kaishi Satomi Japan 17 188 0.8× 274 1.2× 302 1.8× 143 1.0× 139 1.3× 76 978

Countries citing papers authored by Erika J. Lampert

Since Specialization
Citations

This map shows the geographic impact of Erika J. Lampert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika J. Lampert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika J. Lampert more than expected).

Fields of papers citing papers by Erika J. Lampert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika J. Lampert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika J. Lampert. The network helps show where Erika J. Lampert may publish in the future.

Co-authorship network of co-authors of Erika J. Lampert

This figure shows the co-authorship network connecting the top 25 collaborators of Erika J. Lampert. A scholar is included among the top collaborators of Erika J. Lampert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika J. Lampert. Erika J. Lampert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lampert, Erika J., et al.. (2024). Higher incidence of venous thromboembolism associated with increasing lines of treatment in heavily treated ovarian cancer patients. International Journal of Gynecological Cancer. 34(8). 1246–1252.
2.
Huang, Tzu‐Ting, Jayakumar R. Nair, Daniel An, et al.. (2023). BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA -mutant ovarian cancer. Science Translational Medicine. 15(701). eadd7872–eadd7872. 17 indexed citations
3.
Lampert, Erika J., Peter G. Rose, Robert Debernardo, et al.. (2023). Association of Clinical Trial Participation With Improved Overall Survival for Recurrent, Platinum-Resistant Ovarian Cancer. Obstetrical & Gynecological Survey. 78(11). 648–649.
4.
Lampert, Erika J., et al.. (2021). Carving a niche for immunotherapy in ovarian cancer. Oncotarget. 12(1). 4–7.
5.
Lampert, Erika J., Alexandra S. Zimmer, Michelle R. Padget, et al.. (2020). Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study. Clinical Cancer Research. 26(16). 4268–4279. 150 indexed citations
6.
Huang, Tzu‐Ting, et al.. (2020). Targeting the PI3K pathway and DNA damage response as a therapeutic strategy in ovarian cancer. Cancer Treatment Reviews. 86. 102021–102021. 109 indexed citations
7.
Lampert, Erika J., et al.. (2020). Long-term pelvic organ prolapse recurrence and mesh exposure following sacrocolpopexy. International Urogynecology Journal. 31(9). 1763–1770. 20 indexed citations
8.
Chambers, Laura, Erika J. Lampert, Meng Yao, et al.. (2020). Use of prophylactic closed incision negative pressure therapy is associated with reduced surgical site infections in gynecologic oncology patients undergoing laparotomy. American Journal of Obstetrics and Gynecology. 223(5). 731.e1–731.e9. 10 indexed citations
9.
10.
Zolin, Samuel J., Luciano Tastaldi, Hemasat Alkhatib, et al.. (2020). Open retromuscular versus laparoscopic ventral hernia repair for medium-sized defects: where is the value?. Hernia. 24(4). 759–770. 9 indexed citations
11.
12.
Lampert, Erika J., et al.. (2018). Route of hysterectomy during minimally invasive sacrocolpopexy does not affect postoperative outcomes. International Urogynecology Journal. 30(4). 649–655. 19 indexed citations
13.
French, Judith C., Samuel J. Zolin, Erika J. Lampert, et al.. (2018). Gender and Letters of Recommendation: A Linguistic Comparison of the Impact of Gender on General Surgery Residency Applicants✰. Journal of surgical education. 76(4). 899–905. 48 indexed citations
14.
Ortiz-Pérez, Santiago, Magí Andorrà, Bernardo Sánchez‐Dalmau, et al.. (2016). Visual field impairment captures disease burden in multiple sclerosis. Journal of Neurology. 263(4). 695–702. 14 indexed citations
15.
Wei, Lei, Jianmin Wang, Erika J. Lampert, et al.. (2016). Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators. European Urology. 71(2). 183–192. 152 indexed citations
16.
Martínez‐Heras, Eloy, Vesna Prčkovska, Carlos Laredo, et al.. (2015). Improved Framework for Tractography Reconstruction of the Optic Radiation. PLoS ONE. 10(9). e0137064–e0137064. 32 indexed citations
17.
Lampert, Erika J., Magí Andorrà, Rubén Torres–Torres, et al.. (2015). Color vision impairment in multiple sclerosis points to retinal ganglion cell damage. Journal of Neurology. 262(11). 2491–2497. 36 indexed citations
18.
Lampert, Erika J., Kingshuk Roy Choudhury, Bharath Rathakrishnan, et al.. (2014). Brain atrophy rates in first degree relatives at risk for Alzheimer's. NeuroImage Clinical. 6. 340–346. 8 indexed citations
19.
Martínez‐Lapiscina, Elena H., Elena Fraga‐Pumar, Iñigo Gabilondo, et al.. (2014). The multiple sclerosis visual pathway cohort: understanding neurodegeneration in MS. BMC Research Notes. 7(1). 910–910. 28 indexed citations
20.
Lampert, Erika J., et al.. (2013). Prevalence of Alzheimer’s Pathologic Endophenotypes in Asymptomatic and Mildly Impaired First-Degree Relatives. PLoS ONE. 8(4). e60747–e60747. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Quancai Cui Breakdown of academic impact, for papers by Blanca Cantos Breakdown of academic impact, for papers by Anna F. Lee Breakdown of academic impact, for papers by Edwin Alvarez Breakdown of academic impact, for papers by Chiara Della Pepa Breakdown of academic impact, for papers by Meng Huang Breakdown of academic impact, for papers by Hong-Jun Song Breakdown of academic impact, for papers by Matthew Vaughan Breakdown of academic impact, for papers by G Wolf Breakdown of academic impact, for papers by Kaishi Satomi
Rankless by CCL
2026